{"id":78193,"date":"2026-09-02T15:28:16","date_gmt":"2026-09-02T07:28:16","guid":{"rendered":"https:\/\/flcube.com\/?p=78193"},"modified":"2026-09-02T15:28:17","modified_gmt":"2026-09-02T07:28:17","slug":"nhsa-releases-version-3-0-drg-and-dip-grouping-schemes-setting-2027-deadline-for-chinas-disease-based-payment-overhaul","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=78193","title":{"rendered":"NHSA Releases Version 3.0 DRG and DIP Grouping Schemes, Setting 2027 Deadline for China&#8217;s Disease-Based Payment Overhaul"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">China&#8217;s <strong>National Healthcare Security Administration (NHSA)<\/strong> officially released the Version 3.0 Grouping Scheme for Diagnosis-Related Groups (<strong>DRG<\/strong>) Payment and the Version 3.0 Grouping Scheme for Diagnosis-Intervention Packet (<strong>DIP<\/strong>) Payment, marking the next phase of China&#8217;s nationwide shift toward disease-based healthcare reimbursement.<\/p>\n\n\n\n<h2 id=\"h-regulatory-milestone\" class=\"wp-block-heading\">Regulatory Milestone<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Agency<\/th><th>Action<\/th><th>Instrument<\/th><th>Scope<\/th><th>Date<\/th><th>Next Steps<\/th><\/tr><\/thead><tbody><tr><td><strong>NHSA<\/strong> (China)<\/td><td>Policy release<\/td><td>Version 3.0 <strong>DRG<\/strong> Grouping Scheme &amp; Version 3.0 <strong>DIP<\/strong> Grouping Scheme<\/td><td>All regions and medical institutions implementing disease-based payment<\/td><td>02 Sep 2026<\/td><td>Transition preparations by 31 Dec 2026; full implementation by end of Mar 2027<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-version-3-0-grouping-structure\" class=\"wp-block-heading\">Version 3.0 Grouping Structure<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Scheme<\/th><th>Core Elements<\/th><th>Count<\/th><\/tr><\/thead><tbody><tr><td><strong>DRG<\/strong><\/td><td>Adjacent Diagnosis-Related Groups (ADRGs)<\/td><td>492<\/td><\/tr><tr><td><strong>DRG<\/strong><\/td><td>Diagnosis-Related Groups (DRGs)<\/td><td>825<\/td><\/tr><tr><td><strong>DIP<\/strong><\/td><td>Core disease database categories<\/td><td>5,125<\/td><\/tr><tr><td><strong>DRG<\/strong> (primary-level)<\/td><td>Primary-level groups for grassroots care<\/td><td>31<\/td><\/tr><tr><td><strong>DIP<\/strong> (primary-level)<\/td><td>Primary-level diseases for grassroots care<\/td><td>127<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">The Version 3.0 schemes define the first batch of primary-level disease categories to support the development of primary healthcare services, offering local authorities a reference framework for grassroots reimbursement.<\/p>\n\n\n\n<h2 id=\"h-implementation-timeline-amp-compliance-requirements\" class=\"wp-block-heading\">Implementation Timeline &amp; Compliance Requirements<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Transition deadline:<\/strong> Regions and medical institutions implementing disease-based payment must complete transition preparations by <strong>31 Dec 2026<\/strong><\/li>\n\n\n\n<li><strong>Full implementation:<\/strong> Version 3.0 grouping takes effect by the <strong>end of March 2027<\/strong><\/li>\n\n\n\n<li><strong>Refined management:<\/strong> The <strong>NHSA<\/strong> requires strengthened overall payment management, standardized calculation and verification of disease payment rates, and an optimized exceptional case review mechanism to improve audit efficiency<\/li>\n\n\n\n<li><strong>Flexible rate models:<\/strong> Regions with floating rates may explore models such as dividing total disease-based payment into stock (fixed) and increment (floating) portions; fixing rates for severe diseases while floating rates for mild ones; or fixing rates for essential drugs and consumables while applying floating rates to medical service items<\/li>\n\n\n\n<li><strong>Exceptional case review:<\/strong> For new drugs, consumables, and technologies, and for complex and severe cases \u2014 capped at <strong>5%<\/strong> of total <strong>DRG<\/strong> discharged cases in DRG regions, with <strong>DIP<\/strong> quotas moderately optimized and capped at <strong>1%<\/strong> of total discharged cases from 2027 onward<\/li>\n\n\n\n<li><strong>Fund settlement:<\/strong> A three-year action plan will accelerate settlement, optimize fund allocation structure, and advance quarterly settlements, with the policy of &#8220;retaining surplus for retention, sharing reasonable overruns&#8221; enforced<\/li>\n\n\n\n<li><strong>Assessment safeguards:<\/strong> Medical institutions are explicitly prohibited from using disease payment standards as caps for departmental or staff assessments or linking them to performance-based compensation<\/li>\n\n\n\n<li><strong>Data governance:<\/strong> A regular data release mechanism will be established through data working groups, with coordinated advancement of disease-based payment for cross-regional healthcare services<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-impact-amp-outlook\" class=\"wp-block-heading\">Market Impact &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Reimbursement recalibration:<\/strong> The Version 3.0 <strong>DRG<\/strong> and <strong>DIP<\/strong> schemes will reset payment benchmarks across Chinese hospitals, with direct implications for revenue recognition, cost control, and service-line economics<\/li>\n\n\n\n<li><strong>Primary care tailwind:<\/strong> The introduction of 31 <strong>DRG<\/strong> primary-level groups and 127 <strong>DIP<\/strong> primary-level diseases signals policy support for grassroots healthcare providers<\/li>\n\n\n\n<li><strong>Innovation carve-outs:<\/strong> The exceptional case review mechanism for new drugs, consumables, and technologies offers a partial pressure valve for innovative medical products that might otherwise be squeezed by fixed case-based payments<\/li>\n\n\n\n<li><strong>Hospital management pressure:<\/strong> Stricter rate verification and audit efficiency requirements will push hospitals toward more refined clinical and financial data systems<\/li>\n\n\n\n<li><strong>Sector signal:<\/strong> The <strong>NHSA<\/strong>&#8216;s timeline confirms that disease-based payment is becoming the default operating model for China&#8217;s healthcare system, reshaping incentives for providers, payers, and life sciences companies alike<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong> \u2013 This brief contains forward-looking statements regarding the implementation and industry impact of the Version 3.0 DRG and DIP grouping schemes. Actual outcomes may differ materially due to enforcement, regional adoption, and market factors. This content is for informational purposes only and does not constitute investment advice.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China&#8217;s National Healthcare Security Administration (NHSA) officially released the Version 3.0 Grouping Scheme for Diagnosis-Related&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[4],"tags":[110,67],"class_list":["post-78193","post","type-post","status-publish","format-standard","hentry","category-policy-regulatory","tag-drgs","tag-nhsa-prev-smia"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>NHSA Releases Version 3.0 DRG and DIP Grouping Schemes, Setting 2027 Deadline for China&#039;s Disease-Based Payment Overhaul - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China&#039;s National Healthcare Security Administration (NHSA) officially released the Version 3.0 Grouping Scheme for Diagnosis-Related Groups (DRG) Payment and the Version 3.0 Grouping Scheme for Diagnosis-Intervention Packet (DIP) Payment, marking the next phase of China&#039;s nationwide shift toward disease-based healthcare reimbursement.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=78193\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NHSA Releases Version 3.0 DRG and DIP Grouping Schemes, Setting 2027 Deadline for China&#039;s Disease-Based Payment Overhaul\" \/>\n<meta property=\"og:description\" content=\"China&#039;s National Healthcare Security Administration (NHSA) officially released the Version 3.0 Grouping Scheme for Diagnosis-Related Groups (DRG) Payment and the Version 3.0 Grouping Scheme for Diagnosis-Intervention Packet (DIP) Payment, marking the next phase of China&#039;s nationwide shift toward disease-based healthcare reimbursement.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=78193\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-02T07:28:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-02T07:28:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=78193#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=78193\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"NHSA Releases Version 3.0 DRG and DIP Grouping Schemes, Setting 2027 Deadline for China&#8217;s Disease-Based Payment Overhaul\",\"datePublished\":\"2026-09-02T07:28:16+00:00\",\"dateModified\":\"2026-09-02T07:28:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=78193\"},\"wordCount\":572,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"DRGs\",\"NHSA (prev. SMIA)\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=78193#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=78193\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=78193\",\"name\":\"NHSA Releases Version 3.0 DRG and DIP Grouping Schemes, Setting 2027 Deadline for China's Disease-Based Payment Overhaul - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-09-02T07:28:16+00:00\",\"dateModified\":\"2026-09-02T07:28:17+00:00\",\"description\":\"China's National Healthcare Security Administration (NHSA) officially released the Version 3.0 Grouping Scheme for Diagnosis-Related Groups (DRG) Payment and the Version 3.0 Grouping Scheme for Diagnosis-Intervention Packet (DIP) Payment, marking the next phase of China's nationwide shift toward disease-based healthcare reimbursement.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=78193#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=78193\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=78193#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NHSA Releases Version 3.0 DRG and DIP Grouping Schemes, Setting 2027 Deadline for China&#8217;s Disease-Based Payment Overhaul\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"NHSA Releases Version 3.0 DRG and DIP Grouping Schemes, Setting 2027 Deadline for China's Disease-Based Payment Overhaul - Insight, China&#039;s Pharmaceutical Industry","description":"China's National Healthcare Security Administration (NHSA) officially released the Version 3.0 Grouping Scheme for Diagnosis-Related Groups (DRG) Payment and the Version 3.0 Grouping Scheme for Diagnosis-Intervention Packet (DIP) Payment, marking the next phase of China's nationwide shift toward disease-based healthcare reimbursement.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=78193","og_locale":"en_US","og_type":"article","og_title":"NHSA Releases Version 3.0 DRG and DIP Grouping Schemes, Setting 2027 Deadline for China's Disease-Based Payment Overhaul","og_description":"China's National Healthcare Security Administration (NHSA) officially released the Version 3.0 Grouping Scheme for Diagnosis-Related Groups (DRG) Payment and the Version 3.0 Grouping Scheme for Diagnosis-Intervention Packet (DIP) Payment, marking the next phase of China's nationwide shift toward disease-based healthcare reimbursement.","og_url":"https:\/\/flcube.com\/?p=78193","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-09-02T07:28:16+00:00","article_modified_time":"2026-09-02T07:28:17+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=78193#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=78193"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"NHSA Releases Version 3.0 DRG and DIP Grouping Schemes, Setting 2027 Deadline for China&#8217;s Disease-Based Payment Overhaul","datePublished":"2026-09-02T07:28:16+00:00","dateModified":"2026-09-02T07:28:17+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=78193"},"wordCount":572,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["DRGs","NHSA (prev. SMIA)"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=78193#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=78193","url":"https:\/\/flcube.com\/?p=78193","name":"NHSA Releases Version 3.0 DRG and DIP Grouping Schemes, Setting 2027 Deadline for China's Disease-Based Payment Overhaul - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-09-02T07:28:16+00:00","dateModified":"2026-09-02T07:28:17+00:00","description":"China's National Healthcare Security Administration (NHSA) officially released the Version 3.0 Grouping Scheme for Diagnosis-Related Groups (DRG) Payment and the Version 3.0 Grouping Scheme for Diagnosis-Intervention Packet (DIP) Payment, marking the next phase of China's nationwide shift toward disease-based healthcare reimbursement.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=78193#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=78193"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=78193#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"NHSA Releases Version 3.0 DRG and DIP Grouping Schemes, Setting 2027 Deadline for China&#8217;s Disease-Based Payment Overhaul"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/78193","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=78193"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/78193\/revisions"}],"predecessor-version":[{"id":78195,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/78193\/revisions\/78195"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=78193"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=78193"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=78193"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}